Global Pharma Deal Value Rises to $18.3 Billion in July 2025: GlobalData - Express Pharma

Merck, Nordic Capital, and Sanofi Account for 79 Percent of $18.3 Billion Pharmaceutical Deals in July 2025

The global pharmaceutical sector recorded a total deal […] The post Merck, Nordic Capital, and Sanofi Account for 79 Percent of $18.3 Billion Pharmaceutical Deals in July 2025 first appeared on GeneOnline News. The post Merck, Nordic Capital, and Sanofi Account for 79 Percent of $18.3 Billion Pharmaceutical Deals in July 2025 appeared first on GeneOnline News.

Global pharma deal value rises to $18.3 billion in July 2025: GlobalData - Express Pharma

The healthcare industry recorded 69 deals valued at $18.3 billion in July 2025, according to a recent GlobalData report. This marks a decrease in the number of deals compared to the last 12-month average of 95 deals, but an increase in overall deal value, which averaged $13.2 billion between July 2024 and June 2025. One of the key transactions during the month was Merck & Co Inc’s announcement to acquire Verona Pharma Plc, a biopharmaceutical co…